The Asia Pacific Biopsy Devices Market should witness market growth of 8.6% CAGR during the forecast period (2022-2028).
It is anticipated that the market growth will boost by the demand for disposable biopsy devices and less invasive operations. Vacuum-assisted guns are a scientifically advanced biopsy guidance system that is gaining approval from patients and doctors. In addition, the elderly population all over the world is increasing, rising the risk of chronic diseases such as cancer.
An increase in cancer-related expenditure is causing the necessity for effective analytic measures. Regulatory bodies of administration and hospitals worldwide are always involved in decreasing costs related to cancer treatments. Primary and secondary hospitals in developing countries inspire patients to undergo consistent analytical tests.
Using biopsy devices is economically feasible as it means a decrease in the number of days staying in the hospital. Some biopsy tools enable precise positioning of the central stylet and its sample notch before firing the cutting sheath over the stylet. As a result, the needle does not move forward again after firing the gun, minimising potential harm to nearby structures. This is helpful when the lesion is tiny or when it is close to vital organs or veins.
China is among the flourishing healthcare sectors in the world and offers potential for the American exporters in numerous secondary healthcare sectors. The medical equipment of the healthcare sector continues to be the most active and vitally essential segment for international enterprises. By 2028, it is anticipated that Malaysia's healthcare spending will be doubled to USD 2.8 billion.
The China market dominated the Asia Pacific Biopsy Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $225.6 million by 2028.The Japan market is estimated to grow a CAGR of 7.9% during (2022-2028). Additionally, The India market would experience a CAGR of 9.2% during (2022-2028).
Based on Product, the market is segmented into Needle-based Biopsy Guns, Biopsy Guidance Systems, Biopsy Needles, Biopsy Forceps and Others. Based on Needle-based Biopsy Guns Type, the market is segmented into Vacuum-assisted Biopsy (VAB) Devices, Fine Needle Aspiration Biopsy (FNAB) Devices and Core Needle Biopsy (CNB) Devices. Based on Biopsy Guidance Systems Type, the market is segmented into Manual and Robotic. Based on Biopsy Needles Type, the market is segmented into Disposable and Reusable. Based on End-user, the market is segmented into Hospitals, Diagnostic & Imaging Center and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Hologic, Inc., Fujifilm Holdings Corporation, B. Braun Melsungen AG, Danaher Corporation, ConMed Corporation, Becton, Dickinson and Company, Cardinal Health, Inc., Argon Medical Devices, Inc., and Cook Medical, Inc.
It is anticipated that the market growth will boost by the demand for disposable biopsy devices and less invasive operations. Vacuum-assisted guns are a scientifically advanced biopsy guidance system that is gaining approval from patients and doctors. In addition, the elderly population all over the world is increasing, rising the risk of chronic diseases such as cancer.
An increase in cancer-related expenditure is causing the necessity for effective analytic measures. Regulatory bodies of administration and hospitals worldwide are always involved in decreasing costs related to cancer treatments. Primary and secondary hospitals in developing countries inspire patients to undergo consistent analytical tests.
Using biopsy devices is economically feasible as it means a decrease in the number of days staying in the hospital. Some biopsy tools enable precise positioning of the central stylet and its sample notch before firing the cutting sheath over the stylet. As a result, the needle does not move forward again after firing the gun, minimising potential harm to nearby structures. This is helpful when the lesion is tiny or when it is close to vital organs or veins.
China is among the flourishing healthcare sectors in the world and offers potential for the American exporters in numerous secondary healthcare sectors. The medical equipment of the healthcare sector continues to be the most active and vitally essential segment for international enterprises. By 2028, it is anticipated that Malaysia's healthcare spending will be doubled to USD 2.8 billion.
The China market dominated the Asia Pacific Biopsy Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $225.6 million by 2028.The Japan market is estimated to grow a CAGR of 7.9% during (2022-2028). Additionally, The India market would experience a CAGR of 9.2% during (2022-2028).
Based on Product, the market is segmented into Needle-based Biopsy Guns, Biopsy Guidance Systems, Biopsy Needles, Biopsy Forceps and Others. Based on Needle-based Biopsy Guns Type, the market is segmented into Vacuum-assisted Biopsy (VAB) Devices, Fine Needle Aspiration Biopsy (FNAB) Devices and Core Needle Biopsy (CNB) Devices. Based on Biopsy Guidance Systems Type, the market is segmented into Manual and Robotic. Based on Biopsy Needles Type, the market is segmented into Disposable and Reusable. Based on End-user, the market is segmented into Hospitals, Diagnostic & Imaging Center and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Hologic, Inc., Fujifilm Holdings Corporation, B. Braun Melsungen AG, Danaher Corporation, ConMed Corporation, Becton, Dickinson and Company, Cardinal Health, Inc., Argon Medical Devices, Inc., and Cook Medical, Inc.
Scope of the Study
By Product
- Needle-based Biopsy Guns
- Vacuum-assisted Biopsy (VAB) Devices
- Fine Needle Aspiration Biopsy (FNAB) Devices
- Core Needle Biopsy (CNB) Devices
- Biopsy Guidance Systems
- Manual
- Robotic
- Biopsy Needles
- Disposable
- Reusable
- Biopsy Forceps
- Others
By End-user
- Hospitals
- Diagnostic & Imaging Center
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- Hologic, Inc.
- Fujifilm Holdings Corporation
- B.Braun Melsungen AG
- Danaher Corporation
- ConMed Corporation
- Becton, Dickinson and Company
- Cardinal Health, Inc.
- Argon Medical Devices, Inc.
- Cook Medical, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Biopsy Devices Market, by Product
1.4.2 Asia Pacific Biopsy Devices Market, by End User
1.4.3 Asia Pacific Biopsy Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition &Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Biopsy Devices Market by Product
3.1 Asia Pacific Needle-based Biopsy Guns Market by Country
3.2 Asia Pacific Biopsy Devices Market by Needle-based Biopsy Guns Type
3.2.1 Asia Pacific Vacuum-assisted Biopsy (VAB) Devices Market by Country
3.2.2 Asia Pacific Fine Needle Aspiration Biopsy (FNAB) Devices Market by Country
3.2.3 Asia Pacific Core Needle Biopsy (CNB) Devices Market by Country
3.3 Asia Pacific Biopsy Guidance Systems Market by Country
3.4 Asia Pacific Biopsy Devices Market by Biopsy Guidance Systems Type
3.4.1 Asia Pacific Manual Market by Country
3.4.2 Asia Pacific Robotic Market by Country
3.5 Asia Pacific Biopsy Needles Market by Country
3.6 Asia Pacific Biopsy Devices Market by Biopsy Needles Type
3.6.1 Asia Pacific Disposable Market by Country
3.6.2 Asia Pacific Reusable Market by Country
3.7 Asia Pacific Biopsy Forceps Market by Country
3.8 Asia Pacific Others Market by Country
Chapter 4. Asia Pacific Biopsy Devices Market by End User
4.1 Asia Pacific Hospitals Market by Country
4.2 Asia Pacific Diagnostic & Imaging Center Market by Country
4.3 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific Biopsy Devices Market by Country
5.1 China Biopsy Devices Market
5.1.1 China Biopsy Devices Market by Product
5.1.1.1 China Biopsy Devices Market by Needle-based Biopsy Guns Type
5.1.1.2 China Biopsy Devices Market by Biopsy Guidance Systems Type
5.1.1.3 China Biopsy Devices Market by Biopsy Needles Type
5.1.2 China Biopsy Devices Market by End User
5.2 Japan Biopsy Devices Market
5.2.1 Japan Biopsy Devices Market by Product
5.2.1.1 Japan Biopsy Devices Market by Needle-based Biopsy Guns Type
5.2.1.2 Japan Biopsy Devices Market by Biopsy Guidance Systems Type
5.2.1.3 Japan Biopsy Devices Market by Biopsy Needles Type
5.2.2 Japan Biopsy Devices Market by End User
5.3 India Biopsy Devices Market
5.3.1 India Biopsy Devices Market by Product
5.3.1.1 India Biopsy Devices Market by Needle-based Biopsy Guns Type
5.3.1.2 India Biopsy Devices Market by Biopsy Guidance Systems Type
5.3.1.3 India Biopsy Devices Market by Biopsy Needles Type
5.3.2 India Biopsy Devices Market by End User
5.4 South Korea Biopsy Devices Market
5.4.1 South Korea Biopsy Devices Market by Product
5.4.1.1 South Korea Biopsy Devices Market by Needle-based Biopsy Guns Type
5.4.1.2 South Korea Biopsy Devices Market by Biopsy Guidance Systems Type
5.4.1.3 South Korea Biopsy Devices Market by Biopsy Needles Type
5.4.2 South Korea Biopsy Devices Market by End User
5.5 Singapore Biopsy Devices Market
5.5.1 Singapore Biopsy Devices Market by Product
5.5.1.1 Singapore Biopsy Devices Market by Needle-based Biopsy Guns Type
5.5.1.2 Singapore Biopsy Devices Market by Biopsy Guidance Systems Type
5.5.1.3 Singapore Biopsy Devices Market by Biopsy Needles Type
5.5.2 Singapore Biopsy Devices Market by End User
5.6 Malaysia Biopsy Devices Market
5.6.1 Malaysia Biopsy Devices Market by Product
5.6.1.1 Malaysia Biopsy Devices Market by Needle-based Biopsy Guns Type
5.6.1.2 Malaysia Biopsy Devices Market by Biopsy Guidance Systems Type
5.6.1.3 Malaysia Biopsy Devices Market by Biopsy Needles Type
5.6.2 Malaysia Biopsy Devices Market by End User
5.7 Rest of Asia Pacific Biopsy Devices Market
5.7.1 Rest of Asia Pacific Biopsy Devices Market by Product
5.7.1.1 Rest of Asia Pacific Biopsy Devices Market by Needle-based Biopsy Guns Type
5.7.1.2 Rest of Asia Pacific Biopsy Devices Market by Biopsy Guidance Systems Type
5.7.1.3 Rest of Asia Pacific Biopsy Devices Market by Biopsy Needles Type
5.7.2 Rest of Asia Pacific Biopsy Devices Market by End User
Chapter 6. Company Profiles
6.1 Medtronic PLC
6.1.1 Company overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expenses
6.1.5 SWOT Analysis
6.2 Hologic, Inc
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Acquisition and Mergers:
6.3 Fujifilm Holdings Corporation
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expenses
6.4 B. Braun Melsungen AG
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.5 Danaher Corporation
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 ConMed Corporation
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expense
6.7 Becton, Dickinson and Company
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.8 Cardinal Health, Inc.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.9 Argon Medical Devices, Inc.
6.9.1 Company Overview
6.10. Cook Medical, Inc. (Cook Group)
6.10.1 Company Overview
Companies Mentioned
- Medtronic PLC
- Hologic, Inc.
- Fujifilm Holdings Corporation
- B. Braun Melsungen AG
- Danaher Corporation
- ConMed Corporation
- Becton, Dickinson and Company
- Cardinal Health, Inc.
- Argon Medical Devices, Inc.
- Cook Medical, Inc.
Methodology
LOADING...
